drugset / Press release
SOM0226 PRESENTED AT THE XIIITH INTERNATIONAL SYMPOSIUM ON AMYLOIDOSIS
2012-05-05 · SOM Innovation Biotech SA · original sombiotech.com ↗
SOM0226 , a reprofiled drug for the treatment of TTR amyloidosis, has been presented at the XIII th International Symposium on Amyloidosis in Groningen, The Netherlands. The product has been recognized as one of the most promising in-coming therapies by the scientific expert community in the field.
The release as fetched from its publisher. sombiotech.com ↗